Medtronic appointed Dr. Joon Sup Lee to its Board of Directors on June 23.

From Yahoo Finance: 2025-06-28 12:39:00

Medtronic plc (NYSE:MDT) appointed Dr. Joon Sup Lee to its Board of Directors on June 23. Dr. Lee is currently the CEO of Emory Healthcare, Inc. and brings a wealth of experience from his previous roles at the University of Pittsburgh Medical Center. Medtronic is a leading healthcare technology company serving over 79 million patients globally.

Dr. Joon Sup Lee’s appointment to Medtronic’s Board comes as the company expands its Board size. Dr. Lee will serve on key committees, bringing his expertise in healthcare management to the table. With his background in leading academic health systems, Dr. Lee is poised to make valuable contributions to Medtronic’s strategic direction.

Medtronic plc is a healthcare technology company specializing in medical devices and therapies for chronic conditions. With a focus on cardiovascular, neuroscience, surgical, and diabetes products, Medtronic serves millions of patients worldwide. The addition of Dr. Joon Sup Lee to its Board further strengthens the company’s leadership and expertise in the healthcare industry.

Investors looking at Medtronic (MDT) may find potential in the stock, but some believe that certain AI stocks offer better upside potential. For those interested in undervalued AI stocks with growth opportunities, exploring other options may be beneficial. Consider researching AI stocks that could benefit from current market trends and tariffs for potential investment opportunities.

Read more: Medtronic (MDT) Appoints Dr. Joon Sup Lee to Board of Directors